Intellectia LogoIntellectia
Product
Resources
Markets
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns
Daytrading Center

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. AHCO
stocks logo

AHCO

-
Add to WatchlistAdvanced Chart
$
0.000
0(0.000%)1D
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
804.97M
-0.12%
0.158
-26.53%
809.31M
+0.43%
0.337
+53.16%
859.64M
+0.35%
0.512
+21.99%
Estimates Revision
The market is revising Downward the revenue expectations for AdaptHealth Corp. (AHCO) for FY2025, with the revenue forecasts being adjusted by -0.9% over the past three months. During the same period, the stock price has changed by 4.71%.
Revenue Estimates for FY2025
Revise Downward
down Image
-0.9%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+3.66%
In Past 3 Month
Stock Price
Go Up
up Image
+4.71%
In Past 3 Month
4 Analyst Rating
up Image0
Wall Street analysts forecast AHCO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AHCO is 13.50 USD with a low forecast of 13.00 USD and a high forecast of 14.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Buy
0 Hold
0 Sell
Strong Buy
up Image0
Current: 9.110
sliders
Low
13.00
Averages
13.50
High
14.00
up Image0
Current: 9.110
sliders
Low
13.00
Averages
13.50
High
14.00
Truist
Buy
downgrade
$14 -> $13
2025-05-12
Reason
Truist
Price Target
$14 -> $13
2025-05-12
downgrade
Buy
Reason
Truist lowered the firm's price target on AdaptHealth to $13 from $14 and keeps a Buy rating on the shares as part of a broader research note on Health Care Services. The firm is updating its models to reflect Q1 results and updated guidance on select names, the analyst tells investors in a research note.
Baird
Eric Coldwell
Buy
Maintains
$14 → $16
2025-02-27
Reason
Baird
Eric Coldwell
Price Target
$14 → $16
2025-02-27
Maintains
Buy
Reason
Baird raised the firm's price target on AdaptHealth to $16 from $14 and keeps an Outperform rating on the shares. The firm said they posted good Q4 results and a positive 2025 outlook.
Truist Securities
David Macdonald
Strong Buy
Maintains
$12 → $14
2025-02-26
Reason
Truist Securities
David Macdonald
Price Target
$12 → $14
2025-02-26
Maintains
Strong Buy
Reason
RBC Capital
Ben Hendrix
Buy
Maintains
$11 → $14
2025-02-26
Reason
RBC Capital
Ben Hendrix
Price Target
$11 → $14
2025-02-26
Maintains
Buy
Reason
RBC Capital raised the firm's price target on AdaptHealth to $14 from $11 and keeps an Outperform rating on the shares after its Q4 earnings beat. The company saw a strong finish to 2024 and gave solid initial guidance, the analyst tells investors in a research note. Early signs that the strategic overhaul to the Diabetes business announced last quarter may be taking hold, the firm adds.
Canaccord Genuity
Richard Close
Strong Buy
Maintains
$13 → $14
2025-02-26
Reason
Canaccord Genuity
Richard Close
Price Target
$13 → $14
2025-02-26
Maintains
Strong Buy
Reason
Canaccord analyst Richard Close raised the firm's price target on AdaptHealth to $14 from $13 and keeps a Buy rating on the shares. The firm said 4Q was a step forward in rebuilding investor confidence for Adapt as results showed revenue upside and 2025 guidance that has revenue and adj-EBITDA ranges bracketing both Canaccord and consensus prior estimates, and a respectable FCF range of $180-$220 million.
UBS
Whit Mayo
Strong Buy
Maintains
$12 → $11
2025-02-13
Reason
UBS
Whit Mayo
Price Target
$12 → $11
2025-02-13
Maintains
Strong Buy
Reason
See All Ratings

Valuation Metrics

The current forward P/E ratio for Adapthealth Corp (AHCO.O) is 7.56, compared to its 5-year average forward P/E of 15.90. For a more detailed relative valuation and DCF analysis to assess Adapthealth Corp 's fair value, click here.
    Forward PE
    Forward EV/EBITDA
    Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average PE
15.90
Current PE
7.56
Overvalued PE
22.86
Undervalued PE
8.94

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average EV/EBITDA
6.30
Current EV/EBITDA
4.60
Overvalued EV/EBITDA
7.61
Undervalued EV/EBITDA
4.99

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average PS
0.74
Current PS
0.35
Overvalued PS
1.12
Undervalued PS
0.36

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

    Insider
    Hedge Fund
    Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds areBuying! The buying amount has increased 1321.21% over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought

AHCO News & Events

Events Timeline

(ET)
2025-05-06
07:44:38
AdaptHealth cuts FY25 revenue view to $3.18B-$3.32B from $3.22B-$3.36B
select
2025-05-06
07:42:27
AdaptHealth reports Q1 EPS (5c), consensus 4c
select
2025-02-25 (ET)
2025-02-25
07:28:01
AdaptHealth sees FY25 revenue $$3.22B-$3.36B, consensus $3.33B
select
Sign Up For More Events
Sign Up For More Events

News

Preview
3.0
08-04Yahoo Finance
AdaptHealth (AHCO) To Report Earnings Tomorrow: Here Is What To Expect

  • Earnings Report Overview: AdaptHealth Corp. is set to report earnings, with analysts expecting flat revenue of $804 million and adjusted earnings of $0.16 per share, following a previous quarter where it missed EPS estimates and slightly missed full-year revenue guidance.

  • Market Context: The senior health sector has generally underperformed recently, with AdaptHealth's shares down 5.4% over the past month, while peers like BrightSpring Health Services and Option Care Health have shown stronger year-on-year revenue growth.

Preview
7.0
07-02Globenewswire
Important Notice to Long-Term Shareholders of AdaptHealth Corp. (NASDAQ: AHCO); CorMedix Inc. (NASDAQ: CRMD); Napco Security Technologies, Inc. (NASDAQ: NSSC); and Virtu Financial Inc. (NYSE: VIRT): Grabar Law Office is Investigating Claims on Your Behalf as Key Developments Occur in Underlying Class Actions

  • AdaptHealth Corp. Class Action: A federal securities fraud class action against AdaptHealth Corp. has been stayed pending mediation, with allegations of improper billing practices and misleading statements to investors leading to inflated stock prices.

  • Other Companies' Class Actions: Similar shareholder class actions are ongoing for CorMedix Inc., Napco Security Technologies, and Virtu Financial Inc., with allegations of false disclosures and misleading statements affecting their stock performance, all allowing shareholders to seek corporate reforms and potential financial returns.

Preview
9.5
06-27Benzinga
Concentrix Posts Downbeat Earnings, Joins CorMedix And Other Big Stocks Moving Lower In Friday's Pre-Market Session

  • U.S. Stock Market Update: U.S. stock futures are up, with Dow futures gaining over 100 points, while Concentrix Corporation shares fell 8% after reporting mixed second-quarter results, missing earnings estimates but exceeding revenue expectations.

  • Pre-Market Trading Movements: Several stocks experienced declines in pre-market trading, including CorMedix Inc. down 14.2% due to a public offering announcement, and Critical Metals Corp. also down 14.2% after a previous surge.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Adapthealth Corp (AHCO) stock price today?

The current price of AHCO is 9.11 USD — it has increased 4.11 % in the last trading day.

arrow icon

What is Adapthealth Corp (AHCO)'s business?

AdaptHealth Corp. is a provider of patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company provides a full suite of medical products and solutions designed to help patients manage chronic conditions in the home. Its product and service offerings include sleep therapy equipment, supplies, and related services (including CPAP and bi PAP services) to individuals suffering from obstructive sleep apnea; medical devices and supplies to patients for the treatment of diabetes, including continuous glucose monitors and insulin pumps; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs. It operates in 50 states through its network of over 670 locations in 47 states.

arrow icon

What is the price predicton of AHCO Stock?

Wall Street analysts forecast AHCO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AHCO is 13.50 USD with a low forecast of 13.00 USD and a high forecast of 14.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Adapthealth Corp (AHCO)'s revenue for the last quarter?

Adapthealth Corp revenue for the last quarter amounts to 777.88M USD, decreased -1.84 % YoY.

arrow icon

What is Adapthealth Corp (AHCO)'s earnings per share (EPS) for the last quarter?

Adapthealth Corp. EPS for the last quarter amounts to -0.05 USD, increased 150.00 % YoY.

arrow icon

What changes have occurred in the market's expectations for Adapthealth Corp (AHCO)'s fundamentals?

The market is revising Downward the revenue expectations for AdaptHealth Corp. (AHCO) for FY2025, with the revenue forecasts being adjusted by -0.9% over the past three months. During the same period, the stock price has changed by 4.71%.
arrow icon

How many employees does Adapthealth Corp (AHCO). have?

Adapthealth Corp (AHCO) has 10500 emplpoyees as of August 05 2025.

arrow icon

What is Adapthealth Corp (AHCO) market cap?

Today AHCO has the market capitalization of 1.23B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free